Clinical trials: Significant Bleeding Risk
Upper Gastrointestinal Variceal Bleeding in Cirrhotic Patients
Predictive and Prognostic Significance of Age,Blood Tests,Comorbidities(ABC) Score,Cologne Watch(C-watch)Score and Rockall Score for Risk of Variceal Re-bleeding Among Cirrhotic Patients
Introduction Portal hypertension is a common complication of liver cirrhosis and is often underestimated in clinical diagnosis. The incidence of portal hypertension is approximately 20% to 98% in patients with cirrhosis (Wu et…
- Trial name
- NCT06335186
- Testing
- upper endoscopy
- Where
- Egypt
- Volunteers
- 100 people
- Sponsor
- Sohag University
Hemorrhage
Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage
CRASH 2 is a large pragmatic randomised placebo controlled trial of the effects of the early administration of the antifibrinolytic agent tranexamic acid on death, vascular events and transfusion requirements.
- Trial name
- NCT00375258
- Testing
- Tranexamic acid, Sodium Chloride 0.9%
- Where
- United Kingdom
- Volunteers
- 20,211 people
- Sponsor
- London School of Hygiene and Tropical Medicine